Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 08 tags : Fda save search
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: 0.4%
H: 1.16%
C: -6.33%
new drug fda application phase 1 gene therapy therapy drug trial submission
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
SEEL | $0.326 0.09% 0.09% 380K
|
Health Technology
|
| O: 0.9%
H: 4.04%
C: 2.69%
new drug fast track designation treatment fda fda acceptance application fast track drug designation
Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral SolutionThe first and only FDA-approved ready-to-use liquid topiramate
Published: 2021-11-08 (Crawled : 15:00) - biospace.com/
ETON | $3.295 1.39% 1.37% 23K
|
Health Technology
|
| O: -3.14%
H: 0.14%
C: -7.76%
fda fda approval approval
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400 (AAV-NR2E3) to Treat Inherited Retinal Degeneration
Published: 2021-11-08 (Crawled : 15:00) - globenewswire.com
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: 0.4%
H: 1.16%
C: -6.33%
new drug fda application phase 1 gene therapy therapy retina drug trial submission
FDA Action Alert: Liquidia, Adamis and BioMarin
Published: 2021-11-08 (Crawled : 15:00) - biospace.com/
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.7%
fda
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
Published: 2021-11-08 (Crawled : 14:15) - biospace.com/
TLIS | $9.0 0.0% 8.4K
|
|
| O: 9.85%
H: 11.24%
C: 6.38%
covid fda test molecular granted merge sars-cov-2 emergency use authorization
FDA Grants Tentative Approval for Liquidia’s YUTREPIA™ (Treprostinil) Inhalation Powder
Published: 2021-11-08 (Crawled : 11:00) - globenewswire.com
LQDA S | $12.96 -1.67% -1.7% 1.2M
|
Health Technology
|
| O: -1.08%
H: 1.09%
C: -0.98%
fda approval granted grant
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.